RP-HPLC Gradient Elution for Glatiramer Acetate Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current analytical methods struggle to effectively distinguish glatiramer acetate from non-conforming copolymers, which is crucial for ensuring pharmaceutical quality due to the stochastic nature of polymerization and cleavage reactions resulting in varying molecular weights and sequences.
Innovation Solution
A reversed-phase high-performance liquid chromatography (RP-HPLC) method using a stepwise gradient elution approach is employed, allowing for the separation and identification of glatiramer acetate by varying the ratio of water to acetonitrile in the mobile phase, enabling the distinction from non-conforming copolymers and assessment of batches suitable for pharmaceutical use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional analytical methods are used to characterize glatiramer acetate, then the analysis can be performed with standard techniques, but the methods cannot effectively distinguish glatiramer acetate from non-conforming copolymers
Solution Approach 1:
The patent applies parameter changes by optimizing the mobile phase composition (acetonitrile concentration), flow rate, column temperature, and gradient elution profile to achieve baseline separation of glatiramer acetate from non-conforming copolymers. Specifically, the method uses a gradient elution from 10% to 40% acetonitrile over 35 minutes, with the column maintained at 30°C, which resolves the contradiction between measurement precision and method complexity by finding optimal parameters that enhance discrimination capability.
2Manufacturing precision
If a stepwise gradient elution approach is used to separate glatiramer acetate fractions, then clear separation and quantification are achieved, but the analysis time and procedure complexity increase
Solution Approach 1:
The patent employs periodic action through gradient elution, where the mobile phase composition changes in discrete steps (10% to 40% acetonitrile in 35 minutes) rather than isocratic conditions. This periodic change in solvent strength allows different polypeptide fractions to elute at different times based on their hydrophobicity, achieving clear separation while managing analysis time through controlled gradient progression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The RP-HPLC method provides clear separation and quantification of glatiramer acetate fractions, enabling the identification of non-conforming copolymers and ensuring the selection of suitable batches for pharmaceutical use by analyzing peak areas and hydrophobic character, thus addressing the variability in molecular weight and sequence.
Implementation Method 1
reversed phase high-performance liquid chromatography (RP-HPLC)
Implementation Method 2
reversed phase high-performance liquid chromatography (RP-HPLC)
Data Source
AI summary
The present invention relates to reversed phase high-performance liquid chromatography (HPLC) methods useful for the characterisation of glatiramer acetate or similar polypeptide mixtures. The method described herein can distinguish glatiramer acetate from non-conforming copolymers and may be used to choose batches of glatiramer acetate suitable for pharmaceutical use.